At the November meeting, the ACR will advance a resolution that addresses increasing access to telemedicine services for Medicare beneficiaries.
Take Action on Medicare Payment, Telehealth
Medicare physician reimbursement and extension of telehealth flexibilities are two of the ACR’s top legislative priorities as Congress approaches the lame duck session. With physicians facing a 2.8% cut under the 2025 Medicare Physician Fee Schedule proposed rule and telehealth flexibilities set to expire at the end of this year, Congress must hear from the…
Ways You Can Be a Rheumatology Advocate at ACR Convergence 2024
As you make your plans to attend ACR Convergence 2024, keep in mind that the ACR advocacy team will host several events and programs throughout the week. If you have any questions, get in touch with our team at [email protected]. RheumPAC Lounge & Donor Event Investing in RheumPAC is a great way to support the…
ACR-Led Coalition Working Toward Legislative Solutions for Underwater Biosimilars
The Underwater Biosimilars Coalition will meet with the Medicare Payment Advisory Commission to discuss concerns about inadequate reimbursement for certain biosimilars, which has limited beneficiary access to these lower-cost alternative therapies.
Resources for Practices to Fight Payer Downcoding of E/M Services
The American Medical Association and ACR Insurance Subcommittee offer support and guidance to help practices recognize and push back against downcoded payments for evaluation and management services.
Congressional Action Needed to Maintain Medicare’s Extended Telehealth Services
Medicare’s extended telehealth services will expire at the end of the year unless Congress acts to continue them. Make sure your legislators know how a failure to act will harm patient access to care.
ACR Comments on 2025 Physician Fee Schedule
The ACR’s response to the Centers for Medicare & Medicaid Services addresses the likely harm of the proposed conversion factor on the solvency and stability of rheumatology practices. The comments also include recommendations on complex drug administration coding, inflation-adjusted drug rebates and extending telehealth flexibilities.
Draft FDA Guidance No Longer Requires Biosimilar Switching Studies
The updated draft guidance, released in June, would accept an assessment of why data provided meet the switching standard to demonstrate interchangeability of biosimilars
ACR-Led Coalition on Underwater Biosimilars Grows, Charts Next Steps
New members include rheumatology state societies, specialty partners in gastroenterology and patient-facing organizations representing digestive and inflammatory diseases. The ACR and coalition partners are strategizing additional steps to ensure practices receive adequate reimbursement for biosimilars.
Urge Your Lawmakers to Support Critical Medicare Payment Reform
The recently introduced Physician Fee Stabilization Act (S. 4935) would raise the budget neutrality threshold from $20 million to $53 million and help alleviate the annual uncertainty providers face surrounding Medicare reimbursement rates.
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 86
- Next Page »